Overall Survival with Amivantamab–Lazertinib in <i>EGFR</i> -Mutated Advanced NSCLC

J James Chih-Hsin Yang (National Taiwan University Hospital, NTU Cancer Center, Taipei) S Shun Lu H Hidetoshi Hayashi E Enriqueta Felip (Medical Oncology Service, Vall d’Hebron Institute of Oncology, Vall d’Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona) A Alexander I. Spira (Virginia Cancer Specialists and NEXT Oncology-Virginia, Fairfax) N Nicolas Girard (Institut Curie, Institut du Thorax Curie-Montsouris, Paris) Y Yu Jung Kim S Se-Hoon Lee Y Yurii Ostapenko (National Cancer Institute, Kyiv, Ukraine) P Pongwut Danchaivijitr (Division of Medical Oncology, Department of Medicine, Siriraj Hospital Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand) B Baogang Liu (Harbin Medical University Cancer Hospital, Harbin, China) A Adlinda Alip (Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia) E Ernesto Korbenfeld (British Hospital of Buenos Aires, Central British Hospital, Buenos Aires) J Josiane Mourão Dias (Department of Medical Oncology, Barretos Cancer Hospital, São Paulo) B Benjamin Besse A Antonio Passaro (Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan) K Ki-Hyeong Lee (Medical Department, Chungbuk National University Hospital, Cheongju, South Korea) H Hailin Xiong (Department of Medical Oncology, Huizhou Municipal Central Hospital of Guangdong Province, Huizhou, China) S Soon-Hin How (Department of Internal Medicine, Division of Respiratory Medicine, International Islamic University Malaysia Medical Specialist Center, Pahang, Malaysia) Y Ying Cheng (Institute of Biomedical Research, Yunnan University) G Gee-Chen Chang (School of Medicine and Institute of Medicine, Chung Shan Medical University and Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan) H Hiroshige Yoshioka (Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan) M Michael Thomas D Danny Nguyen S Sai-Hong Ignatius Ou (University of California, Irvine School of Medicine, Orange) S Sanjay Mukhedkar (St. John of God Murdoch Hospital, Murdoch, WA, Australia) K Kumar Prabhash (Department of Medical Oncology, Division of Adult Solid Tumor Oncology, Tata Memorial Hospital, Mumbai, India) M Manolo D’Arcangelo (Local Health Unit Authority of Romagna, Ravenna Hospital and Department of Onco-Hematology, Santa Maria delle Croci Hospital of Ravenna, Emilia-Romagna, Italy) J Jorge Alatorre-Alexander (Health Pharma Professional Research, Mexico City) J Juan Carlos Vázquez Limón (Servicio de Oncología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Jalisco, México) S Sara Alves (Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal) D Daniil Stroyakovskiy (Moscow City Oncology Hospital No. 62, Moscow) M Marina Peregudova (Medical Center in Kolomenskoe, Moscow) M Mehmet Ali Nahit Şendur (Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yıldırım Beyazıt University, Ankara, Turkey) O Ozan Yazici (Gazi University Faculty of Medicine Hospital, Ankara, Turkey) R Raffaele Califano V Vanesa Gutiérrez Calderón (Medical Oncology Department, Hospital Regional Universitario de Málaga, Málaga, Spain) F Filippo de Marinis (Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan) S Sang-We Kim (Asan Medical Center, Seoul, South Korea) S Shirish M. Gadgeel (Division of Hematology-Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit) S Scott Owen (Department of Medical Oncology, McGill University Health Centre, Montreal) J John Xie (Johnson &amp; Johnson, Raritan, NJ) T Tao Sun J Jaydeep Mehta (Johnson &amp; Johnson, Spring House, PA) R Raja Venkatasubramanian (Johnson &amp; Johnson, Titusville, NJ) M Mariah Ennis (Johnson &amp; Johnson, Spring House, PA) E Elizabeth Fennema (Johnson &amp; Johnson, San Diego, CA) M Mahesh Daksh (Johnson &amp; Johnson, Raritan, NJ) A Amy Roshak (Johnson &amp; Johnson, Spring House, PA) J Julie Man (Johnson &amp; Johnson, Raritan, NJ) R Roland E. Knoblauch (Johnson &amp; Johnson, Spring House, PA) J Joshua M. Bauml (Johnson &amp; Johnson, Spring House, PA) M Mahadi Baig (Johnson &amp; Johnson, Raritan, NJ) S Sujay Shah (Johnson &amp; Johnson, Spring House, PA) S Seema Sethi (Johnson &amp; Johnson, Spring House, PA) B Byoung Chul Cho

Article Details

Volume / Issue Vol. 393, Issue 17
Published October 30, 2025
Pages 1681-1693
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (56)

J

James Chih-Hsin Yang

National Taiwan University Hospital, NTU Cancer Center, Taipei

S

Shun Lu

H

Hidetoshi Hayashi

E

Enriqueta Felip

Medical Oncology Service, Vall d’Hebron Institute of Oncology, Vall d’Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona

A

Alexander I. Spira

Virginia Cancer Specialists and NEXT Oncology-Virginia, Fairfax

N

Nicolas Girard

Institut Curie, Institut du Thorax Curie-Montsouris, Paris

Y

Yu Jung Kim

S

Se-Hoon Lee

Y

Yurii Ostapenko

National Cancer Institute, Kyiv, Ukraine

P

Pongwut Danchaivijitr

Division of Medical Oncology, Department of Medicine, Siriraj Hospital Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand

B

Baogang Liu

Harbin Medical University Cancer Hospital, Harbin, China

A

Adlinda Alip

Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

E

Ernesto Korbenfeld

British Hospital of Buenos Aires, Central British Hospital, Buenos Aires

J

Josiane Mourão Dias

Department of Medical Oncology, Barretos Cancer Hospital, São Paulo

B

Benjamin Besse

A

Antonio Passaro

Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan

K

Ki-Hyeong Lee

Medical Department, Chungbuk National University Hospital, Cheongju, South Korea

H

Hailin Xiong

Department of Medical Oncology, Huizhou Municipal Central Hospital of Guangdong Province, Huizhou, China

S

Soon-Hin How

Department of Internal Medicine, Division of Respiratory Medicine, International Islamic University Malaysia Medical Specialist Center, Pahang, Malaysia

Y

Ying Cheng

Institute of Biomedical Research, Yunnan University

G

Gee-Chen Chang

School of Medicine and Institute of Medicine, Chung Shan Medical University and Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

H

Hiroshige Yoshioka

Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan

M

Michael Thomas

D

Danny Nguyen

S

Sai-Hong Ignatius Ou

University of California, Irvine School of Medicine, Orange

S

Sanjay Mukhedkar

St. John of God Murdoch Hospital, Murdoch, WA, Australia

K

Kumar Prabhash

Department of Medical Oncology, Division of Adult Solid Tumor Oncology, Tata Memorial Hospital, Mumbai, India

M

Manolo D’Arcangelo

Local Health Unit Authority of Romagna, Ravenna Hospital and Department of Onco-Hematology, Santa Maria delle Croci Hospital of Ravenna, Emilia-Romagna, Italy

J

Jorge Alatorre-Alexander

Health Pharma Professional Research, Mexico City

J

Juan Carlos Vázquez Limón

Servicio de Oncología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Jalisco, México

S

Sara Alves

Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal

D

Daniil Stroyakovskiy

Moscow City Oncology Hospital No. 62, Moscow

M

Marina Peregudova

Medical Center in Kolomenskoe, Moscow

M

Mehmet Ali Nahit Şendur

Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yıldırım Beyazıt University, Ankara, Turkey

O

Ozan Yazici

Gazi University Faculty of Medicine Hospital, Ankara, Turkey

R

Raffaele Califano

V

Vanesa Gutiérrez Calderón

Medical Oncology Department, Hospital Regional Universitario de Málaga, Málaga, Spain

F

Filippo de Marinis

Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan

S

Sang-We Kim

Asan Medical Center, Seoul, South Korea

S

Shirish M. Gadgeel

Division of Hematology-Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit

S

Scott Owen

Department of Medical Oncology, McGill University Health Centre, Montreal

J

John Xie

Johnson &amp; Johnson, Raritan, NJ

T

Tao Sun

J

Jaydeep Mehta

Johnson &amp; Johnson, Spring House, PA

R

Raja Venkatasubramanian

Johnson &amp; Johnson, Titusville, NJ

M

Mariah Ennis

Johnson &amp; Johnson, Spring House, PA

E

Elizabeth Fennema

Johnson &amp; Johnson, San Diego, CA

M

Mahesh Daksh

Johnson &amp; Johnson, Raritan, NJ

A

Amy Roshak

Johnson &amp; Johnson, Spring House, PA

J

Julie Man

Johnson &amp; Johnson, Raritan, NJ

R

Roland E. Knoblauch

Johnson &amp; Johnson, Spring House, PA

J

Joshua M. Bauml

Johnson &amp; Johnson, Spring House, PA

M

Mahadi Baig

Johnson &amp; Johnson, Raritan, NJ

S

Sujay Shah

Johnson &amp; Johnson, Spring House, PA

S

Seema Sethi

Johnson &amp; Johnson, Spring House, PA

B

Byoung Chul Cho